🇳🇱 Netherlands Country × Condition
prostate cancer Clinical Trials in Netherlands
Active clinical trials for prostate cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT07334275
Recruiting
Detection of Minimal Residual Disease Post-prostatectomy
Enrollment
50 pts
Country
🇳🇱 Netherlands
Radboud University Medical Center
View Trial → NCT07260435 Phase 3
Recruiting
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
Enrollment
400 pts
Country
🇳🇱 Netherlands
Nick Beije
View Trial → NCT04228211
Recruiting
Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation
Enrollment
1,500 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial → NCT03034187
Recruiting
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
Enrollment
10,000 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Netherlands?
There are currently 4 active clinical trials for prostate cancer with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Netherlands?
To join a prostate cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Netherlands?
Active prostate cancer trials in Netherlands span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology